Form 4: Moderna President Stephen Hoge Sells 15,000 Shares Under 10b5-1 Trading Plan

Moderna's President, Stephen Hoge, sold 15,000 shares of common stock at $127.49 per share on May 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 15, 2024, Stephen Hoge, President of Moderna, Inc., sold 15,000 shares of Moderna's common stock.
• The sale was executed at a price of $127.49 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on March 15, 2023.
• Following the transaction, Hoge directly owns 1,471,508 shares of Moderna's common stock.
• Hoge also indirectly owns 4,116 shares through Valhalla, LLC and 151,933 shares through a trust for the benefit of his spouse and children.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 trading plan. It doesn't necessarily reflect a negative or positive outlook on the company's future.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, sales under pre-arranged 10b5-1 plans are less indicative of immediate sentiment as they are planned in advance.

Stakeholder Impact

• The sale of shares by a high-ranking executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates